“Fallback” Plan Will Be Main Medicare Rx Program, Medco Predicts
This article was originally published in The Pink Sheet Daily
Executive Summary
The private sector is unlikely to offer stand-alone drug insurance plans under Medicare in 2006, Medco CEO David Snow predicted during the Goldman Sachs conference in Laguna Niguel, Calif. June 9
You may also be interested in...
Medco Warms Up To Part D: Plans "Creative" Role In Medicare Rx
The PBM is now "hopeful" that it can participate in the stand-alone Medicare drug insurance market after previously focusing on the "fallback" opportunity. Medco is working on a "creative and innovative solution" that will resolve its concerns about going at risk.
Medco Warms Up To Part D: Plans "Creative" Role In Medicare Rx
The PBM is now "hopeful" that it can participate in the stand-alone Medicare drug insurance market after previously focusing on the "fallback" opportunity. Medco is working on a "creative and innovative solution" that will resolve its concerns about going at risk.
Aetna Rolls Out Stand-Alone Drug Insurance Plan For Seniors
The policy provides flat co-pays for generic drugs but gives subscribers access to Aetna's negotiated discount rates on mail-order brand drugs. The program is currently only available to Arizona seniors, but will eventually be rolled out to other states.